potential use of machine learning methods to restratify aml patients: 2022 esmo florida
Published 1 year ago • 18 plays • Length 0:39Download video MP4
Download video MP3
Similar videos
-
0:48
current and emerging methods for restratifying acute myeloid leukemia patients: 2022 esmo florida
-
0:50
better molecular understanding, better treatments, and mrd monitoring in aml: 2022 esmo florida
-
0:32
using individualized treatment &multimodality therapy in non-melanoma skin cancer: 2022 esmo florida
-
0:52
getting patients talking about sexual health in cancer – “it’s ok to refer”: 2022 esmo florida
-
53:31
petros koumoutsakos: "machine learning for fluid mechanics"
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
3:18
what is blood cancer?
-
3:22
use of zebrafish sw for myelodysplastic syndrome (mds) & acute myeloid leukemia (aml) studies- ucl
-
0:43
sex and intimacy problems in cancer – commonly experienced and seldom discussed: 2022 esmo florida
-
2:00
testing patients for brca 1/2 mutation – guiding treatment, and reducing risk: 2022 esmo florida
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
0:43
an increasing number of agents with cns penetrance in lung cancer: 2022 esmo florida
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
8:37
how can outcomes be improved in patients with molecularly-defined high-risk aml?
-
1:39
how can mrd guide treatment of aml?
-
1:10
novel methods to assess the effectiveness of chemotherapy in aml patients: mrd
-
3:03
ongoing challenges and unanswered questions in the field of aml
-
1:40
oral combination of hmas venetoclax in unfit or elderly patients with aml
-
5:15
high-risk mds/aml: genomic-driven approaches from ash19 - eytan stein, md
-
1:15
esmo handbook of immuno-oncology
-
3:08
looking beyond bcl-2 inhibition in aml: the potential role of mcl-1 inhibitors and bclxl inhibitors